72 related articles for article (PubMed ID: 12679650)
1. Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates.
Mathisen MS; Kantarjian H; Thomas D; O'Brien S; Jabbour E
Leuk Lymphoma; 2013 Dec; 54(12):2592-600. PubMed ID: 23547835
[TBL] [Abstract][Full Text] [Related]
2. Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Cancer Immunol Immunother; 1989; 29(1):51-6. PubMed ID: 2706640
[TBL] [Abstract][Full Text] [Related]
3. Secondary B-cell acute lymphoblastic leukaemia in a patient with multiple myeloma.
Puliafito B; Oveisi D; Fanous C; El-Masry M
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732365
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab.
Takami A; Hayashi T; Kita D; Nishimura R; Asakura H; Nakao S
Cancer Sci; 2006 Jan; 97(1):80-3. PubMed ID: 16367925
[TBL] [Abstract][Full Text] [Related]
5. Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report.
Marangon M; Casadei B; Broccoli A; Argnani L; Cavo M; Zinzani PL
Clin Case Rep; 2020 Jun; 8(6):933-937. PubMed ID: 32577237
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
Hoelzer D
Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
[TBL] [Abstract][Full Text] [Related]
7. Rituximab used in three cases with relapsed non-Hodgkin's lymphoma.
Elli M; Yilmaz S; Aydin R; Murat S; Bilgici MC; Dagdemir A
Mol Clin Oncol; 2013 May; 1(3):550-552. PubMed ID: 24649209
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for pediatric leukemia.
Shah NN; Dave H; Wayne AS
Front Oncol; 2013; 3():166. PubMed ID: 23847759
[TBL] [Abstract][Full Text] [Related]
9. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.
August KJ; Narendran A; Neville KA
Drugs; 2013 Apr; 73(5):439-61. PubMed ID: 23568274
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
Kantarjian H; Thomas D; Wayne AS; O'Brien S
J Clin Oncol; 2012 Nov; 30(31):3876-83. PubMed ID: 22891271
[No Abstract] [Full Text] [Related]
11. Use of rituximab in three children with relapsed/refractory Burkitt lymphoma.
Akbayram S; Doğan M; Akgün C; Erbey F; Caksen H; Oner AF
Target Oncol; 2010 Dec; 5(4):291-4. PubMed ID: 20859698
[TBL] [Abstract][Full Text] [Related]
12. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Porter DL; Alyea EP; Antin JH; DeLima M; Estey E; Falkenburg JH; Hardy N; Kroeger N; Leis J; Levine J; Maloney DG; Peggs K; Rowe JM; Wayne AS; Giralt S; Bishop MR; van Besien K
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1467-503. PubMed ID: 20699125
[TBL] [Abstract][Full Text] [Related]
13. Application of immunotherapy in pediatric leukemia.
Wayne AS
Curr Hematol Malig Rep; 2009 Jul; 4(3):159-66. PubMed ID: 20425429
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of childhood cancer: from biologic understanding to clinical application.
Wayne AS; Capitini CM; Mackall CL
Curr Opin Pediatr; 2010 Feb; 22(1):2-11. PubMed ID: 19952749
[TBL] [Abstract][Full Text] [Related]
15. Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Maury S; Huguet F; Leguay T; Lacombe F; Maynadié M; Girard S; de Labarthe A; Kuhlein E; Raffoux E; Thomas X; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Rousselot P; Macintyre E; Ifrah N; Dombret H; Béné MC;
Haematologica; 2010 Feb; 95(2):324-8. PubMed ID: 19773266
[TBL] [Abstract][Full Text] [Related]
16. Treatment with rituximab in benign and malignant hematologic disorders in children.
Giulino LB; Bussel JB; Neufeld EJ;
J Pediatr; 2007 Apr; 150(4):338-44, 344.e1. PubMed ID: 17382107
[No Abstract] [Full Text] [Related]
17. Existence of leukemic clones resistant to both imatinib mesylate and rituximab before drug therapies in a patient with Philadelphia chromosome-positive acute lymphocytic leukemia.
Hato T; Yamanouchi J; Tamura T; Hojo N; Niiya Y; Kohno M; Bando S; Yakushijin Y; Takada K; Sakai I; Yasukawa M; Fujita S
Int J Hematol; 2004 Jul; 80(1):62-6. PubMed ID: 15293570
[TBL] [Abstract][Full Text] [Related]
18. Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Corbacioglu S; Eber S; Gungor T; Hummerjohann J; Niggli F
J Pediatr Hematol Oncol; 2003 Apr; 25(4):327-9. PubMed ID: 12679650
[TBL] [Abstract][Full Text] [Related]
19. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
